Allergan plc
AGN
position
long
Wally Weitz
Thesis
The analyst specializing in healthcare has liked Allergan's business, but not the price, suggesting that their current promises about efficiency and growth seem too late, raising questions about their previous performance.
Did it work?
Not analyzed yet — run analysis from the issue page.
Raw excerpt
No raw excerpt stored.